Nahdi Medical Company (TADAWUL:4164)

Market Cap	12.25B -21.2%
Revenue (ttm)	10.37B +5.6%
Net Income	811.26M -3.8%
EPS	6.24 -3.8%
Shares Out	130.00M
PE Ratio	15.10
Forward PE	14.43
Dividend	5.60 (5.94%)
Ex-Dividend Date	Mar 30, 2026

Volume	173,263
Open	95.35
Previous Close	95.35
Day's Range	94.15 - 95.35
52-Week Range	91.00 - 132.10
Beta	0.12
Analysts	Buy
Price Target	125.87 (+33.62%)
Earnings Date	Aug 2, 2026

About Nahdi Medical Company

Nahdi Medical Company, together with its subsidiaries, engages in the wholesale and retail trading of cosmetics, pharmaceutical, special and healthy foods, and medical equipment products in the Kingdom of Saudi Arabia and the United Arab Emirates. The company also offers mom and baby, beauty, and everyday essentials through retail and online stores. In addition, it operates Nahdi Care polyclinic; and provides virtual care services. Further, the company is involved in operating E-Pharmacist platform; and Nahdi Online, an online pharmacy. Additio...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1986
• Employees: 6,182
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4164

Financial Performance

In 2025, Nahdi Medical Company's revenue was 10.21 billion, an increase of 8.12% compared to the previous year's 9.45 billion. Earnings were 830.74 million, an increase of 1.22%.

Analyst Summary

According to 9 analysts, the average rating for 4164 stock is "Buy." The 12-month stock price target is SAR 125.87, which is an increase of 33.62% from the latest price.

Price Target

SAR 125.87

(33.62% upside)

Analyst Consensus: Buy